These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38411905)

  • 1. Optimizing protocols for monitoring
    Faiz NM; Cortes AL; Phang YF; Gimeno IM
    Avian Pathol; 2024 Aug; 53(4):303-311. PubMed ID: 38411905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
    Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
    Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential amplification of Marek's disease CVI988 vaccine and of wild-type isolates from organs of commercial chickens using single or duplexed probes in real-time PCR.
    Davidson I; Natour-Altoury A; Raibstein I; Dahan Y
    Avian Pathol; 2017 Dec; 46(6):610-614. PubMed ID: 28532188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertion of reticuloendotheliosis virus long terminal repeat into the genome of CVI988 strain of Marek's disease virus results in enhanced growth and protection.
    Lupiani B; Lee LF; Kreager KS; Witter RL; Reddy SM
    Avian Dis; 2013 Jun; 57(2 Suppl):427-31. PubMed ID: 23901756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and differentiation of CVI988 (Rispens vaccine) from other serotype 1 Marek's disease viruses.
    Gimeno IM; Dunn JR; Cortes AL; El-Gohary Ael-G; Silva RF
    Avian Dis; 2014 Jun; 58(2):232-43. PubMed ID: 25055627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model.
    Baigent SJ; Smith LP; Currie RJ; Nair VK
    Avian Pathol; 2007 Dec; 36(6):467-74. PubMed ID: 17994325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral kinetics, shedding profile, and transmission of serotype 1 Marek's disease vaccine Rispens/CVI988 in maternal antibody-free chickens.
    Islam T; Renz KG; Walkden-Brown SW; Ralapanawe S
    Avian Dis; 2013 Jun; 57(2 Suppl):454-63. PubMed ID: 23901761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Factors Influencing Efficacy of Vaccine Strain CVI988 Against Marek's Disease in Meat-Type Chickens.
    Gimeno IM; Cortes AL; Faiz NM; Barbosa T; Villalobos T
    Avian Dis; 2015 Sep; 59(3):400-9. PubMed ID: 26478159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Challenge with Oncogenic Marek's Disease Virus Does Not Interfere with Load of Marek's Disease Vaccines DNA in the Feather Pulp at 7 Days of Age.
    R Thiemann TB; Correa M; Cortes AL; Gimeno IM
    Avian Dis; 2022 Mar; 66(1):106-111. PubMed ID: 35308012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of blood and feather pulp samples for the diagnosis of Marek's disease and for monitoring Marek's disease vaccination by real time-PCR.
    Cortes AL; Montiel ER; Lemiere S; Gimeno IM
    Avian Dis; 2011 Jun; 55(2):302-10. PubMed ID: 21793449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of vaccination with CVI988/Rispens on load and replication of a very virulent Marek's disease virus strain in feathers of chickens.
    Haq K; Fear T; Ibraheem A; Abdul-Careem MF; Sharif S
    Avian Pathol; 2012; 41(1):69-75. PubMed ID: 22845323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Md5-BAC-REV-LTR virus as Marek's disease vaccine in commercial meat-type chickens: protection and immunosuppression.
    Ellington C; Cortes AL; Faiz NM; Mays JK; Fadly A; Silva RF; Gimeno IM
    Avian Pathol; 2021 Dec; 50(6):490-499. PubMed ID: 34463588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
    Ralapanawe S; Walkden-Brown SW; Renz KG; Islam AF
    Avian Pathol; 2016; 45(1):26-37. PubMed ID: 26503904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field studies of the detection, persistence and spread of the Rispens CVI988 vaccine virus and the extent of co-infection with Marek's disease virus.
    Ralapanawe S; Renz KG; Burgess SK; Walkden-Brown SW
    Aust Vet J; 2016 Sep; 94(9):329-37. PubMed ID: 27569836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Changes in Viral Loads during Co-Infection with a Recombinant Turkey Herpesvirus Vector Vaccine and Very Virulent Marek's Disease Virus In Vivo.
    Ding T; Xiong M; Xu Y; Pu X; Wang QS; Xu MR; Shao HX; Qian K; Dang HB; Qin AJ
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
    Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
    Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of Efficacy and Replication of Recombinant Vector Vaccines by Using Turkey Herpesvirus Combined with Other Marek's Disease Vaccines.
    Gimeno IM; Cortes AL; Reilley A; Barbosa T; Alvarado I; Koopman R; Martinez A
    Avian Dis; 2019 Jun; 63(2):335-341. PubMed ID: 31251535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek's disease virus.
    Baigent SJ; Nair VK; Le Galludec H
    J Virol Methods; 2016 Jul; 233():23-36. PubMed ID: 26973285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
    Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
    Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.